IRCT20140824018915N10招募中2 期
Evaluation the effect of captopril on definitive patients with COVID-19(second phase)
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 400
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- All
入选标准
- •COVID-19 disease confirmed by imaging (HRCT) or Real Time PCR
排除标准
- •Breastfeeding
- •Bilateral renal artery stenosis
- •Hereditary angioedema
- •NSAID consumtion
- •Patients who have been taking Captopril before undergoing Covid due to other underlying diseases (such as hypertension, heart failure, myocardial infarction, etc.) will not be included in the study.
- •Patients in need of ICU admission
- •The patient participates in any other clinical trial on the corpus associated with therapeutic intervention. (Before entering this study)
研究者
相似试验
招募中
3 期
The effect of captopril on definitive patients with coronavirus pneumoniaCoronavirus pneumonia.This code assigned to a disease diagnosis of COVID-19 confirmed by laboratory testingU07.1IRCT20140824018915N9Mashhad University of Medical Sciences40
进行中（未招募）
不适用
Efficacy and tolerability of captopril oinment 0,1% og 0,3% in atopic dermatitis. A randomised, double-blind, placebocontrolled, doseescalating, intra-individual clinical study.MedDRA version: 9.1Level: LLTClassification code 10003639Term: Atopic dermatitisAtopic DermatitisEUCTR2008-004432-20-DKACE Aps
招募中
2 期
Efficacy of Alprazolam on blood pressure controlEssential (primary) hypertension.Essential (primary) hypertensionIRCT20220423054624N1Shahroud University of Medical Sciences94
尚未招募
3 期
Evaluation of the effect of captopril in the prevention of hand and foot syndrome and in patients with colon cancerColorectal cancer.Malignant neoplasm of colon and rectumC18-19IRCT20130311012782N50Esfahan University of Medical Sciences66
进行中（未招募）
不适用
Efficacy and tolerability of captopril ointment 0,1%, 0,3% and 1,0% in psoriasis vulgaris. A randomised, double-blind, placebocontrolled, doseescalating, intra-individual clinical studyPatients with psoriasis vulgarisMedDRA version: 9.1Level: LLTClassification code 10050576Term: Psoriasis vulgarisEUCTR2008-006004-36-DKACE ApS